Erasmus MC DNA app

How Erasmus MC implements pharmacogenetic reporting with iGene Pharmaco

Pharmacogenetic reporting at Erasmus MC Rotterdam using the iGene Pharmaco platform

Translating pharmacogenetic knowledge into clinical care

Academic Hospital Erasmus MC provides pharmacogenetic profiles to numerous GPs, specialists and medical institutions. To communicate the results to patients, Erasmus MC uses the iGene Pharmaco platform which powers a custom-branded Erasmus app for Android and Apple.

The challenge of scaling personalised medicine

Managing pharmacogenetic data across a large academic network proved complex.
Each dataset required accurate interpretation, uniform reporting and secure exchange with external partners. Manual workflows created pressure on staff and made it difficult to stay fully compliant with European medical data standards. 

Integrating genetic data into a secure, automated system

To remove barriers, Erasmus MC implemented the iGene Pharmaco platform that supports a custom Erasmus-branded application. All processing takes place in a GDPR-compliant and ISO 27001-certified environment, ensuring maximum quality and data security.

Streamlined workflow and standardised patient reporting

The Erasmus MC conducts the DNA analysis itself, after which the iGene pharmaco platform converts the results directly into real-time reports. The same applies to add-ons or updates of the analyses, ensuring that patients always have access to the most up-to-date information. The whole process runs smoothly due to API connections with the Erasmus MC’s systems. This allows employees to create profiles easily, scan barcodes and deliver results, which greatly speeds up the workflow.

Enabling truly personalised prescribing

The partnership between Erasmus MC and iGene Pharmaco shows how pharmacogenetic data can become be integrated into patient care. By automating and standardising the process, Erasmus MC lays a stronger foundation for personalised pharmacotherapy across its network.

Trusted by leading pharmacy organisations and labs

Gamedi
Provincie Gelderland
Radboud Universiteit
Eurofins
Erasmus MC
University of Groningen
VU Amsterdam
illumina
UniLabs
Result Labs
SoPhia Genetics
Therapie op maat

Private. Compliant. Built for clinical environments.

With iGene Pharmaco, pharmacists, doctors, and lab technicians can collaborate securely within one platform to deliver better, more personalised patient care.

Private by design

Private by design

Testing with iGene is 100% anonymous. DNA is strictly separated from personal information.

Based on the latest guidelines

Based on the latest guidelines

We update our reports whenever KNMP/DPWG guidelines change.

Certified and compliant

Certified and compliant

ISO 27001 certified and compliant to DPWG guidelines. Designed for use in healthcare settings.

Explore more cases

  • Pharmacogenetic Passport for Gamedi

    Pharmacogenetic Passport for Gamedi

    iGene Pharmaco provides secure pharmacogenetic testing and reporting for Gamedi’s Pharmacogenetic Passport, supporting personalised and preventive care.

    Pharmacogenetic Passport for Gamedi

    iGene Pharmaco provides secure pharmacogenetic testing and reporting for Gamedi’s Pharmacogenetic Passport, supporting personalised and preventive care.

  • Applying pharmacogenetics in primary care

    Applying pharmacogenetics in primary care

    Pharmacist Vince Maar applies pharmacogenetic DNA testing to optimise medication reviews with GPs, improving therapy safety and outcomes in primary care.

    Applying pharmacogenetics in primary care

    Pharmacist Vince Maar applies pharmacogenetic DNA testing to optimise medication reviews with GPs, improving therapy safety and outcomes in primary care.

  • Erasmus MC DNA app

    Academic Hospital Erasmus MC uses iGene Pharmaco’s secure, ISO-certified platform to deliver validated pharmacogenetic dosing advice directly to patients.

    Erasmus MC DNA app

    Academic Hospital Erasmus MC uses iGene Pharmaco’s secure, ISO-certified platform to deliver validated pharmacogenetic dosing advice directly to patients.

1 3